Drug Topics
CONTINUE TO SITE >

OR WAIT 15 SECS

Drug Topics® and Managed Healthcare Executive® Announce Partnership with Scientia Pharmacy Advisors

January 22, 2021

Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.

Drug Topics®, a leading multimedia resource that has served the pharmacy field for more than 160 years, and Managed Healthcare Executive®, a multimedia platform that provides market intelligence and solutions to C-suite executives of health plans, are pleased to announce a partnership with Scientia Pharmacy Advisors. The partnership will offer educational opportunities in the areas of clinical practice, network distribution development and utilization management in oncology pharmacy.

“We have worked with the founders of Scientia Pharmacy Advisors in several different capacities over the past decade, and we share the goal of advancing science and offering innovative health care solutions,” said Brian Haug, Executive Vice-President, Healthcare of MJH Life Sciences™, parent company of Drug Topics® and Managed Healthcare Executive®. “Through this collaboration, we look forward to building upon that relationship and working together to serve as a trusted resource for pharma and healthcare professionals.”

Through live and virtual formats, Scientia Pharmacy Advisors will leverage the Drug Topics® and Managed Healthcare Executive® industry-leading platforms in the pharmacy and payer verticals to help guide pharma partners and other industry professionals through the complex oncology pharmacy landscape. The content will be produced quarterly and will focus on best practices necessary to provide efficient and optimal care to oncology patients across the country.

‘’The partnership will allow Scientia Pharmacy Advisors to benefit from the experience and national reach of some of the leading brands in our space, most of which we use and trust on a regular basis,” said Jeff Lombardo, PharmD, BCOP, of Scientia Pharmacy Advisors. “This alliance will allow our organization to have greater visibility, resulting in the opportunity to have a greater impact on cancer care across the country.”